Compugroup Medical SE & Co. KGaA (XTRA:COP) will look for M&A opportunities. Michael Rauch, Chief Financial Officer said during the Second Quarter and first half results, “In summarizing and moving to the second half of this year, we certainly feel encouraged and determined to continue living our purpose statement that nobody should suffer or die because at some point medical information was missing. There's a clear indication that the COVID-19 pandemic will cause the health care sector to shift even faster to increasing digitization. Connectivity of health care participants will play a larger role in our customers, doctors, pharmacies, hospitals, will remain at the core of this development. CompuGroup Medical is in an excellent position to benefit from these trends, and we are set for further growth building onto our strong market positions, our crisis-resilient business model with more than 60% of recurring revenues. And we will continue to invest into R&D and pursue value-enhancing M&A opportunities”.